The Woodruff Lab contributes to the Women’s Health Research Institute and Oncofertility Consortium blogs. Read the latest information disseminated from these blogs below:  

Survivors of Childhood Cancer POI Surveillance Recommendations

This report represents a unique collaborative effort among international specialists in the field of oncology and reproductive medicine. An evidence based approach was used to develop recommendations regarding surveillance for premature ovarian insufficiency in female childhood, adolescent and young adult cancer survivors.  In particular, because females exposed to specific gonadotoxic treatments including alkylating agents and ovarian radiation are at highest risk for ovarian insufficiency, these survivors should be monitored closely before and after puberty. The focus of monitoring should be on growth, pubertal development, assessment of menstrual function and measurement of serum FSH and Estradiol. The authors concluded that AMH may be a reasonable adjunct for assessing ovarian reserve in women at least 25 years of age.

Fertility Drugs and Cancer Guideline Issued by ASRM

Recently the American Society for Reproductive Medicine issued a new guideline assessing the impact of fertility drugs on the risk of cancer in women. This guideline was developed after a comprehensive literature search and grading the available data on this topic. The committee concluded that data in this area are limited by retrospective observational studies which have a variety of methodological problems including: small sample sizes, inadequate information about duration and dose of fertility treatment, and limited follow-up. Moreover, the data are confounded by the fact that some women with infertility are at increased risk of breast, ovarian and endometrial cancer. Nonetheless, there is no compelling data suggesting that fertility medications increase the risk of invasive cancers.

Participate in a Fertility Preservation Study

What Are Your Thoughts About Fertility Preservation?

Dr. Teresa K. Woodruff, PhD, Allison Goetsch, MS, CGC, and graduate student Kendra Frome, BS at Northwestern University are looking for participants who would be willing to take a 5-10 minute survey about fertility preservation!

Partners of those who have received a cancer diagnosis are a crucial part of the decision making process and we want your opinion to better understand how we can help you and your loved one!

Please click on the link below to take the survey:

Those who take the survey can enter a drawing for ten $25 visa gift cards!

Teresa Woodruff Visits China to Discuss Oncofertility in the Global Setting

Dr. Teresa Woodruff and Dr. Shuo Xiao attended the 17th International Congress of Endocrinology held conjunction with the 15th Annual Meeting of Chinese Society of Endocrinology from August 31 to September 4, 2016 in Beijing, China.

During their time there, they visited several places to talk about the fertility preservation in China and also the potential collaboration with Oncofertility Consortium and the Global Partners Network.

National Physicians Cooperative

Connecting clinicians and researchers is paramount to the success of translational research within the Oncofertility Consortium.  In order to facilitate the translation from bench to bedside to babies, the Oncofertility Consortium created the National Physicians Cooperative (NPC).  The NPC is a nationwide network of centers dedicated to preserving the fertility of their patients.  Patients with cancer and other serious diseases whose progression or treatment is likely to impair fertility can receive access to the most up to date treatments and clinical research at NPC member sites.  

Postdoctoral Position in Pediatric Fertility and Hormone Preservation and Restoration

Dr. Monica Laronda, formally a postdoc in the Woodruff Lab, is looking for a postdoc to join the Laronda Lab. Below is the job posting. Contact Dr. Laronda for further details.

Postdoctoral Position in Pediatric Fertility and Hormone Preservation and Restoration

A POSTDOCTORAL POSITION is available to study models for restoring fertility and hormone function. The candidate will use piglet models, ovarian follicle culture, physiology assays, and imaging, stem cell and molecular biology techniques to investigate these models. Highly motivated candidates who recently obtained a PhD or MD degree and have a strong background in primary cell culture techniques and analysis should apply.

Interested individuals should send their curriculum vitae, a brief description of their research interests, and the names of three references to:

Endocrine Abnormalities Reported in Aging Childhood Cancer Survivors

A new study published in the Journal of Clinical Oncology reports endocrine abnormalities in aging childhood cancer survivors. The study, a part of the Childhood Cancer Survivor Study,  found "cumulative incidence and prevalence of endocrine abnormalities increased across the lifespan of survivors and risk was significantly higher in survivors exposed to high-risk therapies". Researchers conluded "endocrinopathies in survivors increased substantially over time, underscoring the need for lifelongsubspecialty follow-up of those at risk." 

Read the article in its entirety here:

Watch Archived Media

The Oncofertility Consortium hosts a variety of activities both in-person and online. In order to create enduring educational materials, the OC archives media from all its events and meetings. Previously recorded videos from Virtual Grand Rounds, Oncofertility Conferences, and other training materials are available online to view anytime, from anywhere! Navigating media is easy using the filter feature at the top of the page. To browse archived media and view previously recorded presentations, click here. 

Support Oncofertility Federal Government Changes in Australia

Dr. Antoinette Anazodo, Director of Adolescent and Young Adult Cancer at the Kids Cancer Centre at the Sydney Children's Hospital, and member of the Oncofertility Global Partners Network, is asking for support for Oncofertility Federal government changes in Australia. Below is a message from Dr. Anazodo regarding this important call to action. Please consider submitting a comment in support of these initiatives. It is important for members of the OC to support such initiatives not only to strengthen our network, but also to improve patient care all over the world. For any further questions, feel free to contact Antoinette Anazodo> directly. Note these comments are due July 15, 2016.